EUHealthGov held its fourth Practitioner Perspective on 11th July 2024. We were delighted to host Gloria Ghéquière, Advisor in the Cabinet of the Belgian Deputy Prime Minister and Minister for Social Affairs and Public Health, Frank Vandenbroucke, to discuss the work done on health by the Belgian Presidency of the European Council between January and June 2024.
This period has continued to see a wide range of pressures on healthcare systems beyond the perennial challenge of ageing populations and the implications this has for costs and workforce. For example, climate change not only increases the risk of new pandemics, but also raises questions about the location of hospitals and drinking water installations in flood areas. A further consideration is market challenges as illustrated by increased medicine shortages of cheap basic medicines, as well as increasing costs for new innovative treatments. Against this backdrop what becomes clear is that there is a role for the EU to play with regard to health. The Belgian presidency drew overall on a range of policy proposals to develop further the European Health Union and to help keep health high on the agenda following the European Parliament elections and anticipating a new Commission mandate.
A key focus of the Belgian presidency’s work has been medicine shortages, which received most support across the Member States. This is a structural problem, with a twentyfold increase in medicine shortages seen between 2000 and 2018. Whereas Europe produced just over half (53%) of global active pharmaceutical ingredients in 2000, today production is found in Asia which is explained by an economic model of extreme economic cost-cutting and increased risk. Belgium has been instrumental in launching the idea of a Critical Medicines Act, which would allow investment in critical production in Europe, but also to establish international partnerships to stabilise global supply and to diversify supply chains. Belgium also connected this idea with the solidarity mechanism at EU level which ensures that no patient in the EU should die or experience extreme consequences as a result of medicine shortages.
The Belgian presidency also promoted prevention of non-communicable diseases, by building on pre-existing EU initiatives such as the Beating Cancer Plan, and has recently welcomed the Commission’s recommendations for a Smoke Free Environment. This leads to a range of considerations regarding challenges of implementation, not only in connection with political will, but also how preventive actions may be located in the portfolios of different Directorates-General, and questions of how these do (or do not) work together.
Further topics covered by the Belgian presidency included work on a clinical trial coordination mechanism to be able to carry out publicly and privately-funded clinical trials on a large scale across the EU in a much more efficient way, and finalising negotiations on the European Health Data Space.
More about the Belgian presidency’s work can be found in the Council’s recommendations from June 2024 available here.
The post Summary: Health and the Belgian Presidency: Practitioner Perspective with Gloria Ghéquière appeared first on Ideas on Europe.